Cargando…
Limitation of tube thoracostomy in treating pneumothorax in COVID-19 infected patients. A retrospective cohort study
BACKGROUND: COVID(19) infection is caused by the highly contagious SARS-CoV-2(Severe acute respiratory syndrome coronavirus 2). The first outbreak of this infection was in Wuhan, China in December 2019. Since then, it has spread rapidly across the world, with more than 100000 new cases each day. Amo...
Autores principales: | Al-Ani, Amer, AbuZayda, Heba, Ahmed, Hala, Alobied, Majd, Kabeer, Nijamudeen, Atasi, Anmar, Jakapure, Vidya, Dabit, Toufic, Al-Ani, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290329/ https://www.ncbi.nlm.nih.gov/pubmed/35875057 http://dx.doi.org/10.1016/j.amsu.2022.104171 |
Ejemplares similares
-
Bradycardia after Tube Thoracostomy for Spontaneous Pneumothorax
por: Fashola, Yomi, et al.
Publicado: (2018) -
Antibiotics are not needed during tube thoracostomy for spontaneous pneumothorax: an observational case study
por: Olgac, Guven, et al.
Publicado: (2006) -
Tube Thoracostomy: Complications and Its Management
por: Kesieme, Emeka B., et al.
Publicado: (2012) -
Impact of thyroid disease in patients with atrial fibrillation: Analysis from the JoFib registry
por: Al-Makhamreh, Hanna, et al.
Publicado: (2022) -
Hazards of tube thoracostomy in patients on a ventilator
por: Shaikhrezai, Kasra, et al.
Publicado: (2011)